Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
CALL
Eaton
ETN
$159B
| $1.24M | ﹤0.01% |
+15,400
| New | +$1.17M |
|
2702
Fidus Investment
FDUS
$750M
| $1.24M | ﹤0.01% |
+80,885
| New | +$1.16M |
|
|
FFIC
2703
DELISTED
Flushing Financial
FFIC
| $1.24M | ﹤0.01% |
56,480
+7,889
| +16% | +$178K |
|
|
K
2704
PUT
DELISTED
Kellanova
K
| $1.24M | ﹤0.01% |
+23,004
| New | +$1.23M |
|
|
MNR
2705
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.24M | ﹤0.01% |
93,999
-311,013
| -77% | -$4.13M |
|
2706
CALL
Merit Medical Systems
MMSI
$5.44B
| $1.24M | ﹤0.01% |
20,000
+10,000
| +100% | +$567K |
|
2707
Provident Financial
PROV
$115M
| $1.24M | ﹤0.01% |
62,121
+10,590
| +21% | +$195K |
|
2708
Sportsman's Warehouse
SPWH
$44.1M
| $1.24M | ﹤0.01% |
257,805
+180,896
| +235% | +$974K |
|
|
TGI
2709
DELISTED
Triumph Group
TGI
| $1.24M | ﹤0.01% |
+64,890
| New | +$1.22M |
|
2710
iShares US Real Estate ETF
IYR
$4.67B
| $1.24M | ﹤0.01% |
14,200
+2,090
| +17% | +$173K |
|
|
XYZ
2711
Block Inc
XYZ
$49.7B
| $1.23M | ﹤0.01% |
16,468
-737,726
| -98% | -$53.5M |
|
|
AMED
2712
PUT
DELISTED
Amedisys
AMED
| $1.23M | ﹤0.01% |
+10,000
| New | +$1.26M |
|
2713
Ecopetrol
EC
$34.5B
| $1.23M | ﹤0.01% |
57,458
-417,803
| -88% | -$8.18M |
|
2714
PUT
Wynn Resorts
WYNN
$10.2B
| $1.23M | ﹤0.01% |
+10,300
| New | +$1.23M |
|
|
SIOX
2715
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.23M | ﹤0.01% |
115,475
+52,952
| +85% | +$527K |
|
|
2716
CALL
ConocoPhillips
COP
$158B
| $1.23M | ﹤0.01% |
18,400
-18,100
| -50% | -$1.22M |
|
2717
Appian
APPN
$2.84B
| $1.23M | ﹤0.01% |
35,642
+17,619
| +98% | +$595K |
|
2718
CALL
CF Industries
CF
$19.3B
| $1.23M | ﹤0.01% |
30,000
+10,000
| +50% | +$424K |
|
|
PDS
2719
Precision Drilling
PDS
$1.12B
| $1.22M | ﹤0.01% |
25,544
+24,385
| +2,104% | +$1.1M |
|
|
CONE
2720
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.22M | ﹤0.01% |
+23,272
| New | +$1.22M |
|
2721
Caleres
CAL
$438M
| $1.21M | ﹤0.01% |
+49,136
| New | +$1.4M |
|
2722
Xeris Biopharma Holdings
XERS
$1.59B
| $1.21M | ﹤0.01% |
+120,750
| New | +$1.55M |
|
2723
3D Systems Corp
DDD
$535M
| $1.21M | ﹤0.01% |
112,461
+56,720
| +102% | +$674K |
|
2724
Tredegar Corp
TG
$276M
| $1.21M | ﹤0.01% |
74,925
-34,475
| -32% | -$583K |
|
2725
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$135M
| $1.21M | ﹤0.01% |
+646
| New | +$1.42M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.